MedPath

The effects of Tamarindus indica L. fruit on overweight and besity

Phase 2
Conditions
Obesity.
Morbid obesity
Registration Number
IRCT201608259662N11
Lead Sponsor
Vice Chancellor for research of Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

obese and overweight adults (BMI over 25 and less 39.9); subjects aged over 18 years.
Exclusion criteria: Individuals with a history of diabetes, cardiovascular disease, liver and kidney as well as pregnancy and breastfeeding; Drugs which increase or body weight or are used to lose weight (orlistat, phentermine, diethylpropion, topiramate, bupropion, metformin, SSRI drugs and herbal medicines on the market) from 2 months before the start of the study; Drugs affecting blood lipid levels include statins, fibrates, sex hormones (estrogen, progestins and birth control pills), beta-blockers, alpha-blocker, corticosteroids, isotretinoin, cyclosporine) from 2 months prior to the study and supplements like fish oil which is effect on blood lipids levels

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
BMI. Timepoint: Before and after 6 weeks. Method of measurement: Meters and weight scales.;Total cholestrol. Timepoint: Before and after 6 weeks. Method of measurement: Parss Azmon KIT/Hitachi Device.;HDL. Timepoint: Before and after 6 weeks. Method of measurement: Parss Azmon KIT / Hitachi Device.;LDL. Timepoint: Before and after 6 weeks. Method of measurement: Parss Azmon KIT/Hitachi Device.;TG. Timepoint: Before and after 6 weeks. Method of measurement: Parss Azmon KIT/Hitachi Device.
Secondary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: Before and after 6 weeks. Method of measurement: Sphygmomanometer.
© Copyright 2025. All Rights Reserved by MedPath